Dynavax Stock Analysis

DVAX
 Stock
  

USD 17.44  0.79  4.74%   

The current price rise of Dynavax Technologies could raise concerns from investors as the firm is trading at a share price of 17.44 on 4,062,800 in volume. The company executives may have good odds in positioning the firm resources to exploit market volatility in September. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.19. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Dynavax Technologies partners.
Continue to Investing Opportunities.
  
The Dynavax Technologies stock analysis report makes it easy to digest most publicly released information about Dynavax Technologies and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Dynavax Stock analysis module also helps to analyze the Dynavax Technologies price relationship with some important fundamental indicators such as market cap and management efficiency.

Dynavax Stock Analysis Notes

About 83.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.34. Dynavax Technologies had not issued any dividends in recent years. The entity had 1:10 split on the 10th of November 2014. Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California. Dynavax Technologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 311 people. To learn more about Dynavax Technologies call Eddie Gray at 510 848-5100 or check out www.dynavax.com.

Dynavax Technologies Quarterly Cost of Revenue

83.37 Million

Dynavax Technologies Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Dynavax Technologies' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Dynavax Technologies or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Dynavax Technologies is way too risky over 90 days horizon
Dynavax Technologies appears to be risky and price may revert if volatility continues
Dynavax Technologies has a strong financial position based on the latest SEC filings
Over 83.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Consensus 2022 Day Two Recap - Yahoo Finance

Dynavax Technologies Upcoming and Recent Events

Earnings reports are used by Dynavax Technologies to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Dynavax Technologies previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report24th of February 2022
Next Financial Report5th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End24th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Dynavax Largest EPS Surprises

Earnings surprises can significantly impact Dynavax Technologies' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-05-06
2021-03-31-0.020.010.03150 
2021-08-04
2021-06-30-0.040.020.06150 
2016-08-05
2016-06-30-0.68-0.75-0.0710 
View All Earnings Estimates

Dynavax Technologies SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Dynavax Technologies prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Dynavax Technologies investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Dynavax Technologies specific information freely available to individual and institutional investors to make a timely investment decision.
4th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
9th of June 2022
Unclassified Corporate Event
View
26th of May 2022
Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
5th of May 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
16th of March 2022
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Entry into a Material Definitive Agreement
View
4th of March 2022
Unclassified Corporate Event
View
28th of February 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
14th of February 2022
Unclassified Corporate Event
View

Dynavax Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 2.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Dynavax Technologies's market, we take the total number of its shares issued and multiply it by Dynavax Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Dynavax Profitablity

Dynavax Technologies' profitability indicators refer to fundamental financial ratios that showcase Dynavax Technologies' ability to generate income relative to its revenue or operating costs. If, let's say, Dynavax Technologies is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Dynavax Technologies' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Dynavax Technologies' profitability requires more research than a typical breakdown of Dynavax Technologies' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 23.18 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 30.8 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.31.
Last ReportedProjected for 2022
Return on Investment 39.18  42.27 
Return on Average Assets 0.09  0.10 
Return on Average Equity 0.61  0.66 
Return on Invested Capital 0.20  0.22 
Return on Sales 0.20  0.22 

Management Efficiency

The entity has return on total asset (ROA) of 12.04 % which means that it generated profit of $12.04 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 56.13 %, meaning that it created $56.13 on every $100 dollars invested by stockholders. Dynavax Technologies management efficiency ratios could be used to measure how well dynavax technologies manages its routine affairs as well as how well it operates its assets and liabilities. Return on Investment is likely to rise to 42.27 in 2022. Return on Average Assets is likely to rise to 0.10 in 2022. Dynavax Technologies Total Assets are fairly stable at the moment as compared to the past year. Dynavax Technologies reported Total Assets of 1.04 Billion in 2021. Current Assets is likely to rise to about 1 B in 2022, whereas Assets Non Current are likely to drop slightly above 52.9 M in 2022.
Last ReportedProjected for 2022
Book Value per Share 1.91  2.67 
Enterprise Value over EBIT 19.00  20.50 
Enterprise Value over EBITDA 17.72  19.12 
Price to Book Value 7.59  9.84 
Tangible Assets Book Value per Share 8.92  7.25 
Enterprise Value1.7 B1.8 B
Tangible Asset ValueB1.1 B

Technical Drivers

As of the 9th of August, Dynavax Technologies shows the Downside Deviation of 4.29, mean deviation of 3.81, and Coefficient Of Variation of 495.46. Dynavax Technologies technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze nineteen technical drivers for Dynavax Technologies, which can be compared to its rivals. Please confirm Dynavax Technologies coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Dynavax Technologies is priced favorably, providing market reflects its regular price of 17.44 per share. Given that Dynavax Technologies has jensen alpha of 1.19, we urge you to verify Dynavax Technologies's prevailing market performance to make sure the company can sustain itself at a future point.

Dynavax Technologies Price Movement Analysis

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Dynavax Technologies price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator.
.

Dynavax Technologies Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Dynavax Technologies insiders, such as employees or executives, is commonly permitted as long as it does not rely on Dynavax Technologies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Dynavax Technologies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Paradiso Peter R over two months ago via Macroaxis 
Acquisition by Paradiso Peter R of 22500 shares of Dynavax Technologies subject to Rule 16b-3
Sun Elaine D over two months ago via Macroaxis 
Dynavax Technologies exotic insider transaction detected
Burgess Justin over two months ago via Macroaxis 
Exercise or conversion by Burgess Justin of 6000 shares of Dynavax Technologies subject to Rule 16b-3
Robert Janssen over three months ago via Macroaxis 
Exercise or conversion by Robert Janssen of 10000 shares of Dynavax Technologies subject to Rule 16b-3
Burgess Justin over three months ago via Macroaxis 
Exercise or conversion by Burgess Justin of 6000 shares of Dynavax Technologies subject to Rule 16b-3
Burgess Justin over three months ago via Macroaxis 
Acquisition by Burgess Justin of 13200 shares of Dynavax Technologies subject to Rule 16b-3
Ryan Spencer over three months ago via Macroaxis 
Exercise or conversion by Ryan Spencer of 89250 shares of Dynavax Technologies subject to Rule 16b-3
David Novack over six months ago via Macroaxis 
Acquisition by David Novack of 2500 shares of Dynavax Technologies subject to Rule 16b-3
David Novack over six months ago via Macroaxis 
Sale by David Novack of 20000 shares of Dynavax Technologies
Myers Scott Dunseth over six months ago via Macroaxis 
Acquisition by Myers Scott Dunseth of 45000 shares of Dynavax Technologies subject to Rule 16b-3
David Novack over six months ago via Macroaxis 
Sale by David Novack of 3000 shares of Dynavax Technologies
David Novack over six months ago via Macroaxis 
Sale by David Novack of 17000 shares of Dynavax Technologies

Dynavax Technologies Predictive Daily Indicators

Dynavax Technologies intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Dynavax Technologies stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Dynavax Technologies Forecast Models

Dynavax Technologies time-series forecasting models is one of many Dynavax Technologies' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Dynavax Technologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Dynavax Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Dynavax Technologies stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Dynavax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Dynavax Technologies. By using and applying Dynavax Stock analysis, traders can create a robust methodology for identifying Dynavax entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin 27.34  27.18 
EBITDA Margin 0.22  0.24 
Gross Margin 0.60  0.66 
Profit Margin 0.16  0.18 
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California. Dynavax Technologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 311 people.

Current Dynavax Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Dynavax analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Dynavax analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
29.0Strong Buy2Odds
Dynavax Technologies current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Dynavax analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Dynavax stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Dynavax Technologies, talking to its executives and customers, or listening to Dynavax conference calls.
Dynavax Analyst Advice Details

Dynavax Stock Analysis Indicators

Dynavax Technologies stock analysis indicators help investors evaluate how Dynavax Technologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Dynavax Technologies shares will generate the highest return on investment. By understating and applying Dynavax Technologies stock analysis, traders can identify Dynavax Technologies position entry and exit signals to maximize returns.
Quick Ratio1.52
Fifty Two Week Low7.26
Revenue Growth36.80%
Shares Short Prior Month19.51M
Average Daily Volume Last 10 Day1.89M
Average Daily Volume In Three Month2.94M
Earnings Growth2,851.40%
Shares Percent Shares Out15.34%
Earnings Quarterly Growth3,587.90%
Gross Margins52.68%
Short Percent Of Float19.39%
Forward Price Earnings24.12
Float Shares117.53M
Fifty Two Week High21.39
Enterprise Value To Ebitda10.57
Fifty Day Average13.11
Two Hundred Day Average13.00
Enterprise Value To Revenue3.35
Continue to Investing Opportunities. Note that the Dynavax Technologies information on this page should be used as a complementary analysis to other Dynavax Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Shere Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Dynavax Stock analysis

When running Dynavax Technologies price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Is Dynavax Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dynavax Technologies. If investors know Dynavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dynavax Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
42.5
Market Capitalization
2.1 B
Quarterly Revenue Growth YOY
3.86
Return On Assets
0.2
Return On Equity
0.92
The market value of Dynavax Technologies is measured differently than its book value, which is the value of Dynavax that is recorded on the company's balance sheet. Investors also form their own opinion of Dynavax Technologies' value that differs from its market value or its book value, called intrinsic value, which is Dynavax Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dynavax Technologies' market value can be influenced by many factors that don't directly affect Dynavax Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dynavax Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine Dynavax Technologies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dynavax Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.